EUVIMEDEUVIMED entdecken
Open Access

Identifying ribonucleotide reductase subunit genes as potential lung adenocarcinomas biomarkers using integrated bioinformatics analysis

Jin Shang, Blessed Kondowe, Hui Zhang, Xinming Xie

Malawi Medical Journal · 2024

DOI: 10.4314/mmj.v36i2.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Malawi Medical Journal, 2024. Verfasst von Jin Shang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, PR China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Ribonucleoside Diphosphate Reductase, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Shaanxi Province, Integration of Basic and Clinical Science Project of School of Basic Medical Sciences, Xi'an Jiaotong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Dysregulation of ribonucleotide reductase (RR) subunit genes (RRM1, RRM2 and RRM2B) expression is reported to be involved in the occurrence of various human malignancies. However, the prognostic value of RR subunit genes expression in lung adenocarcinoma (LUAD) patients remains controversial.

Objective

This study aims to analyze the expression profiles, prognostic values, and immune infiltrating associations of RR subunit genes in LUAD to explore whether RR subunit gene expression has value in the prognosis of patients with lung adenocarcinoma (LUAD).Methodology We used multiple search engines to access multiple online bioinformatics databases, including Oncomine, TIMER, GEPIA, Kaplan–Meier Plotter, PrognoScan, the Human Protein Atlas, MD Anderson Cancer Center, UCSC Xena, cBioProtal, TCGA, GEO, DAVID, and STRING databases.

Results

The study found that RRM1 and RRM2 might be an attractive target for treating LUAD, while RRM2B were down-expressed in LUAD (P < 0.05). The study also found that high RRM1 or RRM2 expression, or low RRM2B expression suggested poor prognosis of LUAD patients in both TCGA and GEO databases (P < 0.05). Additionally, our results indicated that RR subunit genes expressions have different characteristics with immune infiltrating, RRM2B had a slight but significant positive correlation with almost every infiltrating immune cells except CD4+ T cells (all P < 0.05). Furthermore, by co-expression gene network analysis of RR subunit genes, we found that five new hub genes (PLK1, AURKA, CDCA8, TTK and CDC45) were significantly positively correlated with RRM1 and RRM2 expression whereas were negatively correlated with RRM2B expression, and these five hub genes were identified to be related with a poor prognosis in LUAD patients (P < 0.05).

Conclusion

The study findings demonstrate that RR subunit genes may be a prognostic marker and therapeutic target for LUAD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorRibonucleoside Diphosphate ReductaseAdenocarcinoma of LungLung NeoplasmsTumor Suppressor ProteinsHumansComputational BiologyPrognosisGene Expression Regulation, NeoplasticMaleFemaleGene Expression ProfilingRibonucleotide ReductasesCell Cycle Proteins

Stichwörter der Autor:innen

bioinformatics analysisbiomarkerslung adenocarcinomaribonucleotide reductase subunit genes

Substanzen

Biomarkers, TumorRibonucleoside Diphosphate ReductaseRRM1 protein, humanribonucleotide reductase M2Tumor Suppressor ProteinsRRM2B protein, humanRibonucleotide ReductasesCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Medical Imaging, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, PR China.
  • Radiology Department, Mzuzu Central Hospital, Mzuzu, Malawi.
  • Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, PR China.

Förderung

  • Natural Science Foundation of Shaanxi Province
  • Integration of Basic and Clinical Science Project of School of Basic Medical Sciences, Xi'an Jiaotong University

Zitieren

APA

Shang, J., Kondowe, B., Zhang, H., & Xie, X. (2024). Identifying ribonucleotide reductase subunit genes as potential lung adenocarcinomas biomarkers using integrated bioinformatics analysis. Malawi Medical Journal. https://doi.org/10.4314/mmj.v36i2.11

Vancouver

Shang J, Kondowe B, Zhang H, Xie X. Identifying ribonucleotide reductase subunit genes as potential lung adenocarcinomas biomarkers using integrated bioinformatics analysis. Malawi Medical Journal. 2024. doi:10.4314/mmj.v36i2.11

BibTeX
@article{Shang2024,
  author = {Shang, Jin and Kondowe, Blessed and Zhang, Hui and Xie, Xinming},
  title = {Identifying ribonucleotide reductase subunit genes as potential lung adenocarcinomas biomarkers using integrated bioinformatics analysis},
  journal = {Malawi Medical Journal},
  year = {2024},
  doi = {10.4314/mmj.v36i2.11}
}
Kostenlos starten →